BCL2L1 and follicular lymphoma: CD40L stimulation of the neoplastic B-cells derived from the lymph nodes of patients with follicular lymphoma induced NFκB, accompanied by rapid upregulation of Bcl-xL and c-FLIP, leading to TRAIL resistance [46].